Gene · 9260
Papers4,249
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 4,249
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| miRNAs in Herpesvirus Infection: Powerful Regulators in Small Packages. | Viruses | 2023 | 36851643 | PubTator, text mining | PubMed |
| The role of Epstein-Barr virus in nasopharyngeal carcinoma. | Front Microbiol | 2023 | 36846758 | PubTator, text mining | PubMed |
| Exosomes: The Role in Tumor Tolerance and the Potential Strategy for Tumor Therapy. | Pharmaceutics | 2023 | 36839784 | PubTator, text mining | PubMed |
| Epstein-Barr Virus and the Pathogenesis of Diffuse Large B-Cell Lymphoma. | Life (Basel) | 2023 | 36836878 | PubTator, text mining | PubMed |
| The Role of V-Set Ig Domain-Containing 4 in Chronic Kidney Disease Models. | Life (Basel) | 2023 | 36836636 | PubTator, text mining | PubMed |
| CAR-Based Immunotherapy of Solid Tumours-A Survey of the Emerging Targets. | Cancers (Basel) | 2023 | 36831514 | PubTator, text mining | PubMed |
| Protein Kinase CK2 and Epstein-Barr Virus. | Biomedicines | 2023 | 36830895 | PubTator, text mining | PubMed |
| When AHR signaling pathways meet viral infections. | Cell Commun Signal | 2023 | 36829212 | PubTator, text mining | PubMed |
| Insight into Oncogenic Viral Pathways as Drivers of Viral Cancers: Implication for Effective Therapy. | Curr Oncol | 2023 | 36826111 | PubTator, text mining | PubMed |
| TPM2 attenuates progression of prostate cancer by blocking PDLIM7-mediated nuclear translocation of YAP1. | Cell Biosci | 2023 | 36823643 | PubTator, text mining | PubMed |
| Kidney involvement of chronic active Epstein-Barr virus infection. | EJHaem | 2023 | 36819161 | PubTator, text mining | PubMed |
| Liquid metal enabled conformal electronics. | Front Bioeng Biotechnol | 2023 | 36815876 | PubTator, text mining | PubMed |
| Expression of soluble CD27 in extranodal natural killer/T-cell lymphoma, nasal type: potential as a biomarker for diagnosis and CD27/CD70-targeted therapy. | Cancer Immunol Immunother | 2023 | 36811663 | PubTator, text mining | PubMed |
Clear cell renal cell carcinoma with cystic component similar to multilocular cystic renal neoplasm of low malignant potential: a rare pattern of cyst-dependent progression from multilocular cystic renal neoplasm of low malignant potential. | Diagn Pathol | 2023 | 36810118 | PubTator, text mining | PubMed |
| Organ and cell-specific biomarkers of Long-COVID identified with targeted proteomics and machine learning. | Mol Med | 2023 | 36809921 | PubTator, text mining | PubMed |
| Mutations in latent membrane protein 1 of Epstein-Barr virus are associated with increased risk of posttransplant lymphoproliferative disorder in children. | Am J Transplant | 2023 | 36796762 | PubTator, text mining | PubMed |
| Enterovirus A71 Promotes Exosome Secretion by the Nonstructural Protein 3A Interacting with Rab27a. | Microbiol Spectr | 2023 | 36790212 | PubTator, text mining | PubMed |
| Epstein-Barr Virus-Positive Lymphomas Exploit Ectonucleotidase Activity To Limit Immune Responses and Prevent Cell Death. | mBio | 2023 | 36786572 | PubTator, text mining | PubMed |
| Emerging predictive biomarkers for novel therapeutics in peripheral T-cell and natural killer/T-cell lymphoma. | Front Immunol | 2023 | 36776886 | PubTator, text mining | PubMed |
| Cellular transformation promotes the incorporation of docosahexaenoic acid into the endolysosome-specific lipid bis(monoacylglycerol)phosphate in breast cancer. | Cancer Lett | 2023 | 36773796 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9260/papers?page=19